← Leaderboards
Daniel F. Hoft
Saint Louis University
$50,608,486
Attributed
$52,131,774
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,131,774 · 13
By mechanism
UM1$34,607,781 · 1
R01$14,856,568 · 5
R21$2,197,125 · 5
R56$375,000 · 1
S10$95,300 · 1
Top collaborators
- Jianguo Liu4 shared
- Daved H Fremont1 shared
Most similar at Saint Louis University
Same institution · by research overlap
- Robert B. Belshe$24,085,110
- Sharon E. Frey$1,100,040
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityResponseVaccine DevelopmentVaccinesPathogenMolecularInfectionTuberculosis VaccinesRecombinantsViralBcg VaccineAdjuvantTuberculosisMucous MembraneCollaborationsCytokineUniversitiesResearch PersonnelVaccine EvaluationProteinsInfluenza Virus VaccineInfluenzaAntigensInfluenza A Virus, H1n1 Subtype
Grant awards (58)
Vaccine and Treatment Evaluation Unit at Saint Louis University$2,792,722
UM1 · FY2025 · AI · contact PI
Th9 cells and protective TB immunity$667,594
R01 · FY2025 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$1,189,190
UM1 · FY2024 · AI · contact PI
Th9 cells and protective TB immunity$667,594
R01 · FY2024 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$855,721
UM1 · FY2023 · AI · contact PI
Universal T cell targeted influenza vaccine$731,376
R01 · FY2023 · AI · contact PI
Th9 cells and protective TB immunity$667,594
R01 · FY2023 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$1,780,596
UM1 · FY2022 · AI · contact PI
Universal T cell targeted influenza vaccine$741,275
R01 · FY2022 · AI · contact PI
Th9 cells and protective TB immunity$667,594
R01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$587,832
UM1 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$272,027
UM1 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$151,855
UM1 · FY2022 · AI · contact PI
COVID-19 Supplement #5 for CoVPN Novavax Study$5,352,745
UM1 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$3,849,776
UM1 · FY2021 · AI · contact PI
COVID-19 Supplement #4 for CoVPN 5002 Prevalence Study$2,229,401
UM1 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University - DMID 20-0034$753,743
UM1 · FY2021 · AI · contact PI
Universal T cell targeted influenza vaccine$753,206
R01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$596,290
UM1 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$502,177
UM1 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$305,489
UM1 · FY2021 · AI · contact PI
COVID-19 Supplement #3 Moderna Trial$11,154,495
UM1 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$1,627,722
UM1 · FY2020 · AI · contact PI
Universal T cell targeted influenza vaccine$796,383
R01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Unit at Saint Louis University$606,000
UM1 · FY2020 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$753,335
R01 · FY2019 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$761,813
R01 · FY2018 · AI · contact PI
Protective and pathologic effects of Th17 cells specific for an intracellular pathogen$189,375
R21 · FY2018 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$782,578
R01 · FY2017 · AI · contact PI
Protective and pathologic effects of Th17 cells specific for an intracellular pathogen$227,250
R21 · FY2017 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$668,643
R01 · FY2016 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$222,535
R01 · FY2015 · AI · contact PI
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS$376,200
R01 · FY2014 · AI
Universal T cell targeted influenza vaccine$187,500
R21 · FY2014 · AI · contact PI
Universal T cell targeted influenza vaccine$225,000
R21 · FY2013 · AI · contact PI
Development of Novel Chagas Vaccines$187,500
R21 · FY2013 · AI · contact PI
Development of Novel Chagas Vaccines$225,000
R21 · FY2012 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$353,343
R01 · FY2011 · AI · contact PI
Trypanosoma cruzi Mucosal & Systemic Protective Immunity$375,000
R56 · FY2010 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$356,913
R01 · FY2010 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$360,518
R01 · FY2009 · AI · contact PI
Trypanosoma cruzi Mucosal & Systemic Protective Immunity$370,000
R01 · FY2008 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$360,518
R01 · FY2008 · AI · contact PI
Role of gamma/delta T cells in Vaccine Induced Immunity$379,001
R01 · FY2007 · AI · contact PI
Trypanosoma cruzi Mucosal & Systemic Protective Immunity$376,330
R01 · FY2007 · AI · contact PI
Trypanosoma cruzi Mucosal & Systemic Protective Immunity$358,864
R01 · FY2006 · AI · contact PI
Trypanosoma cruzi Mucosal &Systemic Protective Immunity$367,500
R01 · FY2005 · AI
Vaccine Induced Mucosal Protection Against TB Infection$294,000
R21 · FY2005 · AI
Role of gammadelta T Cells in Vaccine-Induced Immunity$367,500
R01 · FY2004 · AI
Vaccine Induced Mucosal Protection Against TB Infection$294,000
R21 · FY2004 · AI
Trypanosoma cruzi Mucosal &Systemic Protective Immunity$214,375
R01 · FY2004 · AI
Role of gammadelta T Cells in Vaccine-Induced Immunity$367,500
R01 · FY2003 · AI
Trypanosoma cruzi Mucosal/Systemic Protective Immunity$367,500
R21 · FY2003 · AI
Role of gammadelta T Cells in Vaccine-Induced Immunity$368,125
R01 · FY2002 · AI
TRYPANOSOMA CRUZI MUCOSAL &SYSTEMIC PROTECTIVE IMMUNITY$342,670
R01 · FY2002 · AI
TRYPANOSOMA CRUZI MUCOSAL &SYSTEMIC PROTECTIVE IMMUNITY$332,691
R01 · FY2001 · AI
TRYPANOSOMA CRUZI MUCOSAL &SYSTEMIC PROTECTIVE IMMUNITY$323,000
R01 · FY2000 · AI
ABI PRISM 7700 SEQUENCE DETECTOR$95,300
S10 · FY2000 · RR